Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Lactic acid/citric acid/potassium bitartrate
Combination of | |
---|---|
Lactic acid | Alpha hydroxy acid |
Citric acid | Tricarboxylic acid |
Potassium bitartrate | Sugar acid salt |
Clinical data | |
Trade names | Phexxi |
AHFS/Drugs.com | Multum Consumer Information |
License data | |
Routes of administration |
Intravaginal |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
KEGG |
Lactic acid/citric acid/potassium bitartrate, sold under the brand name Phexxi, is a non-hormonal combination medication used as a method of birth control. It contains lactic acid, citric acid, and potassium bitartrate. It is a gel inserted into the vagina.
The most common adverse reactions include vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.
Medical uses
The combination is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
History
The combination was approved for medical use in the United States in May 2020.
External links
- "Lactic acid". Drug Information Portal. U.S. National Library of Medicine.
- "Citric acid". Drug Information Portal. U.S. National Library of Medicine.
- "Potassium bitartrate". Drug Information Portal. U.S. National Library of Medicine.
Comparison | |||||
---|---|---|---|---|---|
Behavioral |
|
||||
Barrier and / or spermicidal | |||||
Hormonal (formulations) |
|
||||
Anti-estrogen |
|
||||
Post-intercourse | |||||
Intrauterine device | |||||
Sterilization |
|
||||
Experimental | |||||
Long-acting reversible contraception (LARC) |